REQUEST A DEMO
Total
USD $0.00
Search more companies

Solepharm SIA (Latvia)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Solepharm SIA Profile Updated: December 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Solepharm SIA is based in Latvia. The head office is in Marupes municipality. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on January 08, 2009. The total number of employees is currently 11 (2023). From the latest financial highlights, Solepharm SIA reported a net sales revenue increase of 1.5% in 2024. During that time, Solepharm SIA’s total assets decreased by 0.53%. Solepharm SIA’s net profit margin increased by 1.57% in 2024.

Headquarters
Marupes pag., Jaunmarupe, Alksnu iela 4
Marupes municipality; Marupes municipality; Postal Code: 2166

Contact Details: Purchase the Solepharm SIA report to view the information.

Basic Information
Total Employees:
Purchase the Solepharm SIA report to view the information.
Registered Capital:
Purchase the Solepharm SIA report to view the information.
Financial Auditors:
Purchase the Solepharm SIA report to view the information.
Incorporation Date:
January 08, 2009
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Solepharm SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
1.5%
Total operating revenue
1.23%
Operating profit (EBIT)
46.23%
EBITDA
46.23%
Net Profit (Loss) for the Period
22.09%
Total Assets
-0.53%
Total Equity
8.27%
Operating Profit Margin (ROS)
3.44%
Net Profit Margin
1.57%
Return on Equity (ROE)
3.97%
Quick Ratio
-0.05%
Cash Ratio
0.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?